LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Curis…

Curis Tech Stack

Curis uses 8 technology products and services including jQuery CDN, Open Graph, OneDrive, and more. Explore Curis's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Open Graph
    Content Management System
  • OneDrive
    File Sharing
  • Google Cloud
    Infrastructure As A Service
  • Underscore.js
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Paylocity
    Recruitment Marketing
  • Yoast SEO
    Search Engines

Media & News

Curis's Email Address Formats

Curis uses at least 1 format(s):
Curis Email FormatsExamplePercentage
FLast@curis.comJDoe@curis.com
80%
Last@curis.comDoe@curis.com
15%
First@curis.comJohn@curis.com
3%
LFirst@curis.comDJohn@curis.com
2%

Frequently Asked Questions

Where is Curis's headquarters located?

Minus sign iconPlus sign iconCuris's main headquarters is located at Lexington, Massachusetts 02421 United States. The company has employees across 5 continents, including North AmericaAsiaEurope.

What is Curis's phone number?

Minus sign iconPlus sign icon You can contact Curis's main corporate office by phone at
+1-617-503-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Curis's stock symbol?

Minus sign iconPlus sign iconCuris is a publicly traded company; the company's stock symbol is CRIS.

What is Curis's official website and social media links?

Minus sign iconPlus sign iconCuris's official website is curis.com and has social profiles on LinkedInCrunchbase.

What is Curis's SIC code NAICS code?

Minus sign iconPlus sign iconCuris's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Curis have currently?

Minus sign iconPlus sign iconAs of June 2026, Curis has approximately 155 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: J. D.Cso: L. R.Chief Development Officer (cdo): J. Z.. Explore Curis's employee directory with LeadIQ.

What industry does Curis belong to?

Minus sign iconPlus sign iconCuris operates in the Biotechnology Research industry.

What technology does Curis use?

Minus sign iconPlus sign iconCuris's tech stack includes jQuery CDNOpen GraphOneDriveGoogle CloudUnderscore.jsjQueryPaylocityYoast SEO.

What is Curis's email format?

Minus sign iconPlus sign iconCuris's email format typically follows the pattern of FLast@curis.com. Find more Curis email formats with LeadIQ.

How much funding has Curis raised to date?

Minus sign iconPlus sign icon As of June 2026, Curis has raised $7M in funding. The last funding round occurred on Jul 02, 2025 for $7M.

When was Curis founded?

Minus sign iconPlus sign iconCuris was founded in 2000.

Curis

Biotechnology ResearchMassachusetts, United States51-200 Employees

Curis is a publicly traded biotechnology company based in Lexington, Massachusetts, focused on developing first-in-class cancer therapeutics. It has drug candidates in development, including Emavusertib (CA-4948), an oral IRAK4 kinase inhibitor in Phase 1 trials for non-Hodgkin's lymphoma and for AML/MDS; and Fimepinostat, an oral HDAC/PI3K inhibitor under evaluation for future studies. 

Curis collaborates with Aurigene for discovery and development in immuno-oncology and precision oncology, and holds exclusive licenses to oral PD1/TIM3 dual antagonists such as CA-327 as well as IRAK4 inhibitors like CA-4948. Roche and Genentech, as collaborators, are commercializing Erivedge (vismodegib) for advanced basal cell carcinoma. In May 2026 Curis released its first-quarter 2026 business update.

Section iconCompany Overview

Headquarters
Lexington, Massachusetts 02421 United States
Phone number
+1-617-503-****
Website
curis.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CRIS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $7M

    Curis has raised a total of $7M of funding over 10 rounds. Their latest funding round was raised on Jul 02, 2025 in the amount of $7M.

  • $10M$25M

    Curis's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $7M

    Curis has raised a total of $7M of funding over 10 rounds. Their latest funding round was raised on Jul 02, 2025 in the amount of $7M.

  • $10M$25M

    Curis's revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    J. D.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. R.
    Cso
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. Z.
    Chief Development Officer (cdo)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. D.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. M.
    Chief Scientific Officer At Curis
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    L. R.
    Cso
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    Owner
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. E. L.
    Vice President, Clinical Science
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. P.
    Vice President, Clinical Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. R.
    Head Of Medical Writing, Executive Director
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.